Harel Insurance Investments & Financial Services’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,150
Closed -$96K 723
2022
Q3
$96K Sell
1,150
-900
-44% -$77.4K ﹤0.01% 387
2022
Q2
$163K Buy
2,050
+1,550
+310% +$150K ﹤0.01% 353
2022
Q1
$52K Sell
500
-300
-38% -$24.9K ﹤0.01% 508
2021
Q4
$60K Hold
800
﹤0.01% 563
2021
Q3
$52K Hold
800
﹤0.01% 532
2021
Q2
$158K Hold
800
﹤0.01% 609
2021
Q1
$144K Buy
+800
New +$43.5K ﹤0.01% 604
2019
Q4
Sell
-600
Closed -$30K 533
2019
Q3
$30K Sell
600
-7,200
-92% -$367K ﹤0.01% 358
2019
Q2
$417K Buy
7,800
+3,800
+95% +$198K 0.02% 125
2019
Q1
$211K Sell
4,000
-12,024
-75% -$626K 0.01% 120
2018
Q4
$753K Sell
16,024
-1,104
-6% -$57.6K 0.05% 97
2018
Q3
$988K Sell
17,128
-2,539
-13% -$141K 0.05% 102
2018
Q2
$1.07M Sell
19,667
-14,579
-43% -$723K 0.06% 88
2018
Q1
$1.62M Buy
+34,246
New +$1.72M 0.09% 81

Other funds holding NTR

Harel Insurance Investments & Financial Services's NTR Position: Q4 2022 in Review

Harel Insurance Investments & Financial Services sold out of Nutrien (NTR) in Q4 2022, closing a stake of 1,150 shares — an estimated $96K sold.

Harel Insurance Investments & Financial Services first reported a position in NTR in Q1 2018 and held it in 14 quarters. The position peaked at $1.62M in Q1 2018. 696 funds tracked by Wall St. Rank hold NTR as of Q4 2022.

  • Harel Insurance Investments & Financial Services reported no remaining Nutrien position as of Q4 2022 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,150 Nutrien shares in Q4 2022, an estimated $96K.
  • Harel Insurance Investments & Financial Services first reported a position in Nutrien in Q1 2018 and held it in 14 quarters.
  • Harel Insurance Investments & Financial Services's Nutrien position peaked at $1.62M in Q1 2018.
  • 696 funds tracked by Wall St. Rank held Nutrien as of Q4 2022.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2022, filed 26 Jan 2023.